Peter Paras Jr.

Array ( [id] => 1181363 [patent_doc_number] => 06740794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/494149 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 21647 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740794.pdf [firstpage_image] =>[orig_patent_app_number] => 09494149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167600 [patent_doc_number] => 06753139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Gene silencing' [patent_app_type] => B1 [patent_app_number] => 09/491549 [patent_app_country] => US [patent_app_date] => 2000-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753139.pdf [firstpage_image] =>[orig_patent_app_number] => 09491549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521984 [patent_doc_number] => 06414218 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Mouse model for rheumatoid arthritis' [patent_app_type] => B1 [patent_app_number] => 09/483897 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 31 [patent_no_of_words] => 4413 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414218.pdf [firstpage_image] =>[orig_patent_app_number] => 09483897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534381 [patent_doc_number] => 06489141 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue' [patent_app_type] => B1 [patent_app_number] => 09/479645 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 35 [patent_no_of_words] => 89640 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489141.pdf [firstpage_image] =>[orig_patent_app_number] => 09479645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335592 [patent_doc_number] => 06593139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Initiation of full mammalian oocyte activation by multiple sperm components' [patent_app_type] => B1 [patent_app_number] => 09/478848 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12058 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593139.pdf [firstpage_image] =>[orig_patent_app_number] => 09478848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625612 [patent_doc_number] => 06723557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Caenorhabditis elegans LOV-1 gene' [patent_app_type] => B1 [patent_app_number] => 09/479467 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 44259 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723557.pdf [firstpage_image] =>[orig_patent_app_number] => 09479467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597359 [patent_doc_number] => 06492575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Method for developing transgenic mice' [patent_app_type] => B1 [patent_app_number] => 09/242406 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7623 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492575.pdf [firstpage_image] =>[orig_patent_app_number] => 09242406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7644069 [patent_doc_number] => 06428969 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Method for determining oncogenic activity of a substance' [patent_app_type] => B1 [patent_app_number] => 09/473456 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9157 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428969.pdf [firstpage_image] =>[orig_patent_app_number] => 09473456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324239 [patent_doc_number] => 06331614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Human CDC14A gene' [patent_app_type] => 1 [patent_app_number] => 9/468872 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33771 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331614.pdf [firstpage_image] =>[orig_patent_app_number] => 468872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1546754 [patent_doc_number] => 06444873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'MSH5 ablated mice and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/469636 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 35 [patent_no_of_words] => 8672 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444873.pdf [firstpage_image] =>[orig_patent_app_number] => 09469636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508472 [patent_doc_number] => 06441156 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Calcium channel compositions and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/470443 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 45964 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441156.pdf [firstpage_image] =>[orig_patent_app_number] => 09470443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6698330 [patent_doc_number] => 20030110524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'TRANSGENIC ORGANISMS AND THEIR USES' [patent_app_type] => new [patent_app_number] => 09/460559 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8470 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20030110524.pdf [firstpage_image] =>[orig_patent_app_number] => 09460559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890458 [patent_doc_number] => 20020013952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Self-contained system for sustained viral replication' [patent_app_type] => new [patent_app_number] => 09/460555 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14816 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013952.pdf [firstpage_image] =>[orig_patent_app_number] => 09460555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1587309 [patent_doc_number] => 06359193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Nucleotide sequences of lats genes' [patent_app_type] => B1 [patent_app_number] => 09/442100 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 15 [patent_no_of_words] => 51549 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359193.pdf [firstpage_image] =>[orig_patent_app_number] => 09442100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6349367 [patent_doc_number] => 20020035733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'CONGENIC ANIMAL MODELS OF NON-INSULIN DEPENDENT DIABETES MELLITUS' [patent_app_type] => new [patent_app_number] => 09/434066 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14654 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035733.pdf [firstpage_image] =>[orig_patent_app_number] => 09434066 [rel_patent_id] =>[rel_patent_doc_number] =>)